Castle Biosciences, Inc.
CSTL
$22.05
$0.914.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.59M | 2.27M | 8.92M | -2.53M | -2.58M |
| Total Depreciation and Amortization | 5.77M | 3.54M | 3.35M | 3.34M | 3.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.02M | 16.75M | 9.82M | 11.16M | 10.28M |
| Change in Net Operating Assets | 1.98M | 776.00K | 1.91M | -18.80M | 7.67M |
| Cash from Operations | 24.37M | 23.34M | 24.00M | -6.84M | 18.59M |
| Capital Expenditure | -7.57M | -6.38M | -5.23M | -9.15M | -3.79M |
| Sale of Property, Plant, and Equipment | 7.00K | 4.00K | 2.00K | 5.00K | 3.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.33M | -8.42M | -16.19M | -10.55M | -3.88M |
| Cash from Investing | 5.77M | -14.79M | -21.42M | -19.70M | -7.67M |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 10.00M | -- |
| Total Debt Repaid | -26.00K | -24.00K | -11.00K | -36.00K | -36.00K |
| Issuance of Common Stock | 1.02M | 2.16M | 668.00K | 1.15M | 754.00K |
| Repurchase of Common Stock | -6.38M | -1.29M | -615.00K | -474.00K | -4.02M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.39M | 838.00K | 42.00K | 10.64M | -3.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.75M | 9.39M | 2.62M | -15.89M | 7.62M |